Supplementary Table S2 from Resistance to Durvalumab and Durvalumab Plus Tremelimumab is Associated with Functional <i>stk11</i> Mutations in Patients with Non–Small Cell Lung Cancer and is Reversed by STAT3 Knockdown
openalex（2023）
Key words
Tumor Mutational Burden
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined